StonvexLoading…
StonvexStonvexStonvexCore line items from MKSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.93B | $3.59B | $3.62B | $3.55B |
Operating Income | $528.00M | $498.00M | $-1.55B | $617.00M |
Net Income | $295.00M | $190.00M | $-1.84B | $333.00M |
EPS (Diluted) | $4.37 | $2.81 | $-27.54 | $5.56 |
Total Assets | $8.80B | $8.59B | $9.12B | $11.49B |
Total Liabilities | $6.08B | $6.27B | $6.65B | $7.01B |
Cash & Equivalents | $418.00M | $420.00M | $507.00M | $909.00M |
Free Cash Flow OCF − CapEx | $497.00M | $410.00M | $232.00M | $365.00M |
Shares Outstanding | 67.20M | 67.40M | 66.90M | 66.60M |